CytoSPAR is a biomolecular engineering and diagnostic testing company.
CytoSPAR has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.
CytoSPAR's investors include KittyHawk.
CytoSPAR is headquartered in Easton, United States.
CytoSPAR is a biomolecular engineering and diagnostic testing company.
CytoSPAR is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoSPAR — Funding & Investors." VCBacked, May 3, 2022, https://www.vcbacked.co/company/cytospar. Accessed August 6, 2026.
VCBacked. (2022). CytoSPAR — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/cytospar
{{cite web |title=CytoSPAR — Funding & Investors |url=https://www.vcbacked.co/company/cytospar |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated